DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

47.87 0.53 (1.12%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $47.87 1.12%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.08
Previous Close $47.34
Daily Range $46.88 - $48.47
52-Week Range $30.05 - $52.33
Market Cap $6.0B
P/E Ratio -71.73
Dividend (Yield) $0.00 (0.0%)
Volume 877,727
Average Daily Volume 894,962
Current FY EPS -$0.80

Sector

Healthcare

Industry

Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary Rss Feed

Still Profitless in Seattle Genetics

But a growth opportunity is around the corner.

Seattle Genetics (SGEN) Loss Widens in Q2, Ups 2015 View - Analyst Blog

Seattle Genetics (SGEN) Clay B. Siegall on Q2 2015 Results - Earnings Call Transcript

Seattle Genetics (SGEN) Q2 2015 Results - Earnings Call Webcast

First Week of SGEN March 2016 Options Trading

How To Make Money In Small To Nano-Cap Biotech

Interesting SGEN Put And Call Options For August 21st

Seattle Genetics' Collaborative Approach To Fighting Cancer Makes It A Buy

Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations at the Intern

Seattle Genetics Announces Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations at the International Conference on Malignant Lymphoma

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutic

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutics - Press Releases

See More SGEN News...

SGEN's Top Competitors

SGEN $47.87 (1.12%)
Current stock: SGEN
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB